Diabetes, Vol 49, Issue 3 521-524, Copyright © 2000 by American Diabetes Association

ARTICLES

A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria

S De Cosmo, A Argiolas, G Miscio, S Thomas, GP Piras, R Trevisan, PC Perin, S Bacci, L Zucaro, M Margaglione, L Frittitta, A Pizzuti, V Tassi, GC Viberti and V Trischitta
Division and Research Unit of Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy. endocrinologia@operapadrepio.it

Insulin resistance characterizes type 1 diabetes in patients with albuminuria. A PC-1 glycoprotein amino acid variant, K121Q, is associated with insulin resistance. We examined the impact of the PC-1 K121Q variant on the rate of decline of the glomerular filtration rate (GFR) by creatinine clearance derived from the Cockroft-Gault formula in 77 type 1 diabetic patients with albuminuria who were followed for an average of 6.5 years (range 2.5-15). Patients carrying the Q allele (n = 22; 20 with KQ and 2 with QQ genotypes) had a faster GFR decline than those patients with the KK genotype (n = 55) (median 7.2 vs. 3.7 ml x min(-1) x year(-1); range 0.16 to 16.6 vs. -3.8 to 16.0 ml x min(-1) x year(-1); P < 0.001). Significantly more patients carrying the Q allele belonged to the highest tertile of GFR decline (odds ratio = 5.7, 95% CI 4.1-7.2, P = 0.02). Levels of blood pressure, HbA1c, and albuminuria were comparable in the two genotype groups. Albuminuria (P = 0.001), mean blood pressure (P = 0.046), and PC-1 genotype (P = 0.036) independently correlated with GFR decline. Because all patients were receiving antihypertensive treatment, the faster GFR decline in the patients carrying the Q allele could be the result of reduced sensitivity to the renoprotective effect of antihypertensive therapy. PC-1 genotyping identifies type 1 diabetic patients with a faster progression of diabetic nephropathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. L. Keene, J. C. Mychaleckyj, S. G. Smith, T. S. Leak, P. S. Perlegas, C. D. Langefeld, B. I. Freedman, S. S. Rich, D. W. Bowden, and M. M. Sale Association of the Distal Region of the Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Gene With Type 2 Diabetes in an African-American Population Enriched for Nephropathy Diabetes, April 1, 2008; 57(4): 1057 - 1062. [Abstract] [Full Text] [PDF]

				M. L. Stone, M. E. Craig, A. K. Chan, J. W. Lee, C. F. Verge, and K. C. Donaghue Natural History and Risk Factors for Microalbuminuria in Adolescents With Type 1 Diabetes: A longitudinal study. Diabetes Care, September 1, 2006; 29(9): 2072 - 2077. [Abstract] [Full Text] [PDF]

				K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]

				S. De Cosmo, A. Marucci, E. Ciociola, R. Di Paola, L. Pucci, G. Penno, S. Del Prato, G. P. Piras, R. Trevisan, S. Giunti, et al. Lack of evidence for the 1484insG variant at the 3'-UTR of the protein tyrosine phosphatase 1B (PTP1B) gene as a genetic determinant of diabetic nephropathy development in type 1 diabetic patients Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2419 - 2420. [Full Text] [PDF]

				S. De Cosmo, R. Trevisan, M. Dalla Vestra, M. Vedovato, A. Argiolas, A. Solini, A. Saller, F. Damone, A. Tiengo, V. Trischitta, et al. PC-1 Amino Acid Variant Q121 Is Associated With a Lower Glomerular Filtration Rate in Type 2 Diabetic Patients With Abnormal Albumin Excretion Rates Diabetes Care, October 1, 2003; 26(10): 2898 - 2902. [Abstract] [Full Text] [PDF]

				M. Marre A KQ121 variant in the PC-1 gene and diabetic nephropathy: discrepant results between North and South Europe Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1546 - 1547. [Full Text] [PDF]

				S. D. Cosmo, G. Miscio, L. Zucaro, M. Margaglione, A. Argiolas, S. Thomas, G. Piras, R. Trevisan, P. C. Perin, S. Bacci, et al. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1402 - 1407. [Abstract] [Full Text] [PDF]

				P. Jacobsen, N. Grarup, L. Tarnow, H.-H. Parving, and O. Pedersen PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1408 - 1412. [Abstract] [Full Text] [PDF]

				L. H. Canani, D. P.K. Ng, A. Smiles, J. J. Rogus, J. H. Warram, and A. S. Krolewski Polymorphism in Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 Gene (ENPP1/PC-1) and Early Development of Advanced Diabetic Nephropathy in Type 1 Diabetes Diabetes, April 1, 2002; 51(4): 1188 - 1193. [Abstract] [Full Text] [PDF]

				L. Tarnow, N. Grarup, T. Hansen, H.-H. Parving, and O. Pedersen Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1653 - 1656. [Abstract] [Full Text] [PDF]

				B. V. Costanzo, V. Trischitta, R. Di Paola, D. Spampinato, A. Pizzuti, R. Vigneri, and L. Frittitta The Q Allele Variant (GLN121) of Membrane Glycoprotein PC-1 Interacts With the Insulin Receptor and Inhibits Insulin Signaling More Effectively Than the Common K Allele Variant (LYS121) Diabetes, April 1, 2001; 50(4): 831 - 836. [Abstract] [Full Text]